Glucose uptake assay-guided fractionations of the methanol extract of Schisandra chinensis led to the isolation of the dibenzocyclooctadiene lignans: gomisin J (1), gomisin N (2), wuweizisu B (3), wuweizisu C (4), gomisin C (5), gomisin D (6), (+)-schisandrin A (7), schisandrin C (8), schisandrol A (9), gomisin H (10), angeloylgomisin H (11), gomisin A (12), and schizandrin (13). Among these, 1, 2, 7, and 8 significantly improved basal glucose uptake in HepG2 cells. Their improving effects were concentration-dependent. Compound 2 exhibited a stronger effect than that of rosiglitazone, which has been used as an anti-diabetic drug. The results suggest that these lignans may partially contribute to the anti-diabetic activity of Fructus Schisandrae Chinensis in traditional use by stimulating the glucose uptake into peripheral tissue, which may be responsible for reducing the level of blood glucose in circulation. Thus, these findings show the potential of these lignans for development as hypoglycemic drugs.
Type 2 diabetes mellitus is one of the most common metabolic diseases that is difficult to treat effectively in the long term and leads to many fatal complications [1] . The failure of increasing glucose uptake into peripheral tissues elevates the level of glucose in the circulation and leads to hyperglycemia. The treatment for diabetes mellitus involves either administration of exogenous insulin or oral hypoglycemic drugs. To satisfy a large proportion of patients, methods for screening small molecule compounds with potential hypoglycemic effects have been developed in anti-diabetic medical research [2] [3] [4] , but continuous effort is necessary to discover more hypoglycemic drugs with high potency and little or no side effects.
Fructus Schisandrae Chinensis is the dried ripe fruits of Schisandra chinensis (Turcz.) Baill (Magnoliaceae). It has been used for diabetic treatment, as suggested by the Chinese Pharmacopoeia [5] . The extracts of Fructus Schisandrae Chinensis have been indicated to significantly inhibit glucose absorption in the intestine and stimulate glucose uptake into peripheral tissue [6] . Previous chemical investigations have revealed that the active ingredients of Fructus Schisandrae Chinensis are dibenzocyclooctadiene lignans, which possess diverse biological activities, such as antioxidant, anti-cancer, and anti-HIV [7] [8] [9] . As part of our continuing search for bioactive natural products, we investigated the lignans of S. chinensis for improving basal glucose uptake.
In our screening program, a n-hexane-soluble extract of Fructus Schisandrae Chinensis showed a relative fluorescence intensity (FI) value of 99.0 at 100 μg/mL, which exhibited a potential effect on stimulating glucose uptake compared with the vehicle-treated control group (IF value 49.0). Further fractionation of the n-hexane-soluble extract led to the isolation of 13 dibenzocyclooctadiene lignans, which were identified as gomisin J (1), gomisin N (2), wuweizisu B (3), wuweizisu C (4), gomisin C (5), gomisin D (6), (+)-schisandrin A (7) , schisandrin C (8), schisandrol A (9), gomisin H (10), angeloylgomisin H (11), gomisin A (12), and schizandrin (13) by analysis and comparison of the spectral data with those in the literature (Figure 1 ) [10] [11] [12] [13] [14] [15] [16] .
The effects of the isolated compounds on stimulating glucose uptake were tested in vitro using the HepG2 human hepatocellular carcinoma line [4] . Among all the isolated compounds examined at 100 μM, the lignans, 1, 2, 7 and 8 significantly increased basal glucose uptake ( Figure 2 ). The stimulating effects of these metabolites were concentration-dependent ( Figure 2 ). Compound 2 examined at 10 μM exhibited a stronger effect than that of rosiglitazone, which has been used as an anti-diabetic drug. However, 1-100 µM of 3-6 and 9-13 were inactive.
A previous report indicated that S. chinensis exhibits a significant inhibitory effect on glucose absorption in the BBMV glucose uptake assay and stimulatory effects of glucose uptake in cellular glucose uptake assays of both Hs68 and 3T3-L1 cells [6] . The inhibitory effect on glucose absorption in the intestine may be partially attributed to the water-soluble α-glucosidase inhibitors present in Fructus Schisandrae Chinensis, which were shown to inhibit α-glucosidase in vitro and decrease blood glucose level in alloxan-induced diabetic mice [17] .
The current research suggested that some of the dibenzocyclooctadiene lignans in Fructus Schisandrae Chinensis increased basal glucose uptake in HepG2 cells. These lignans may contribute in part to the anti-diabetic activity of Fructus Schisandrae Chinensis in traditional use by stimulating the glucose uptake into peripheral tissue, which may be responsible for reducing the level of blood glucose in the circulation. Thus, the findings show the potential for developing these lignans as hypoglycemic drugs. However, further investigations are needed to validate their in vitro and in vivo effects. 
Extraction and isolation:
The dried fruit of S. chinensis (10 kg) was extracted 3 times with methanol under reflux. The combined extract was conc. under vacuum, suspended in water, partitioned with n-hexane, and then conc. to dryness to yield 500 g of n-hexanesoluble extract. This was found to stimulate 2-NBDG uptake in HepG2 cells. Therefore, this fraction was subjected to silica gel column chromatography, using gradient elution with n-hexane-acetone (100:1, 75:1, 50:1, 25:1, 1:1; 5000 ml for each step), to yield 8 fractions (SC1~8). SC3 was subjected to further silica gel column chromatography, eluting with n-hexaneacetone (50:1) to yield 1 (200 mg). SC4 was applied to a silica gel column and eluted with n-hexane-acetone (30:1) to give 2 (2500 mg), 3 (15 mg), 4 (28 mg), 5 (10 mg), 6 (300 mg), 7 (60 mg), 8 (30 mg), 9 (20 mg), 10 (72 mg), and 11 (15 mg) . SC7 was subjected to a silica gel column and eluted with n-hexane-acetone (7.5:1) to obtain 12 (800 mg), and 13 (800 mg). The purity of the isolated compounds ranged from 95−98%, as determined by analytical HPLC.
Cell culture: HepG2 human hepatocarcinoma cells were cultured in DMEM growth medium with 10% fetal bovine serum (FBS). Cells were maintained in an atmosphere of humidified 5% CO 2 at 37°C. Glucose uptake assay: Glucose uptake assay was performed using flow cytometry with 2-NBDG as a fluorescent indicator, as previously described, with some modifications [4] . In brief, HepG2 cells were seeded into 96 well plates at 1×10 5 cells/well for 1 day. Cells were treated either with or without tested samples in the absence or presence of 10 μM 2-NBDG for 1 h. After being removed from the medium and washed twice with pre-cold phosphate-buffered saline (PBS), cells were transferred into 5 mL polystyrene roundbottomed tubes (BD Falcon, Bedford, MA, USA) using 500 μL pre-cold fresh medium and maintained at 4°C. The fluorescence intensity of 2-NBDG was recorded using FACScalibur (Becton Dickinson, USA) flow cytometry. Data from 1,000 single-cell events were collected. The Flow Cytometry Standard (FCS) files were opened using software WinMDI (version 2.9) as dot plot style and then converted to text files. The 2-NBDG uptake of single cells was expressed as the average of fluorescence intensities recorded from 1,000 cell events. The relative fluorescence intensity (FI) was calculated as the difference between the fluorescence intensity of a single cell treated with or without tested sample in the presence of 2-NBDG and the fluorescence intensity of a single cell treated with or without a tested sample in the absence of 2-NBDG.
